Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,781 INR | +1.19% | +4.01% | +7.88% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.88% | 2.78B | |
-18.02% | 8.43B | |
+69.46% | 4.35B | |
-1.93% | 2.64B | |
-14.28% | 1.77B | |
-56.54% | 1.74B | |
-16.69% | 1.48B | |
+17.87% | 1.22B | |
-49.60% | 1.02B | |
+10.83% | 922M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates